(Q79733061)

English

Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?

scientific article published on 01 May 2006

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

title

Are class II phosphoinositide 3-kinases potential targets for anticancer therapies? (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

author name string

Colin J Traer

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Fiona M Foster

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Siemon M Abraham

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Michael J Fry

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

publication date

1 May 2006

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

volume

93

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

issue

5

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

page(s)

E53-8

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 December 2019

Identifiers

PubMed ID

16777618

1 reference

stated in

Europe PubMed Central

PubMed ID

16777618

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16777618%20AND%20SRC:MED&resulttype=core&format=json

(Q79733061)

Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)